You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 020222


✉ Email this page to a colleague

« Back to Dashboard


NDA 020222 describes COLESTID, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. Additional details are available on the COLESTID profile page.

The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 020222
Tradename:COLESTID
Applicant:Pfizer
Ingredient:colestipol hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020222
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for 020222
Suppliers and Packaging for NDA: 020222
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLESTID colestipol hydrochloride TABLET;ORAL 020222 NDA Pharmacia & Upjohn Company LLC 0009-0450 0009-0450-03 120 TABLET in 1 BOTTLE (0009-0450-03)
COLESTID colestipol hydrochloride TABLET;ORAL 020222 NDA AUTHORIZED GENERIC Greenstone LLC 59762-0450 59762-0450-1 120 TABLET in 1 BOTTLE (59762-0450-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Jul 19, 1994TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.